Magnetic resonance imaging predictors of treatment response in first-episode schizophrenia

Philip R. Szeszko, Katherine L. Narr, Owen R. Phillips, Joanne McCormack, Serge Sevy, Handan Gunduz-Bruce, John M. Kane, Robert M. Bilder, Delbert G. Robinson

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Identifying neurobiological predictors of response to antipsychotics in patients with schizophrenia is a critical goal of translational psychiatry. Few studies, however, have investigated the relationship between indices of brain structure and treatment response in the context of a controlled clinical trial. In this study, we sought to identify magnetic resonance (MR) imaging measures of the brain that predict treatment response in patients experiencing a first-episode of schizophrenia. Structural MR imaging scans were acquired in 39 patients experiencing a first-episode of schizophrenia with minimal or no prior exposure to antipsychotics participating in a double-blind 16-week clinical trial comparing the efficacy of risperidone vs olanzapine. Twenty-five patients were classified as responders by meeting operationally defined treatment response criteria on 2 consecutive study visits. Fourteen patients never responded to antipsychotic medication at any point during the clinical trial. MR imaging scans were also acquired in 45 age-and sex-matched healthy volunteers. Cortical pattern matching methods were used to compare cortical thickness and asymmetry measures among groups. Statistical mapping results, confirmed by permutation testing, indicated that responders had greater cortical thickness in occipital regions and greater frontal cortical asymmetry compared with nonresponders. Moreover, among responders, greater thickness in temporal regions was associated with less time to respond. Our findings are consistent with the hypothesis that plasticity and cortical thickness may be more preserved in responders and that MR imaging may assist in the prediction of antipsychotic drug response in patients experiencing a first-episode of schizophrenia.

Original languageEnglish
Pages (from-to)569-578
Number of pages10
JournalSchizophrenia Bulletin
Volume38
Issue number3
DOIs
Publication statusPublished - May 2012

Fingerprint

Schizophrenia
Magnetic Resonance Imaging
Antipsychotic Agents
olanzapine
Therapeutics
Clinical Trials
Occipital Lobe
Risperidone
Controlled Clinical Trials
Brain
Temporal Lobe
Psychiatry
Healthy Volunteers

Keywords

  • asymmetry
  • gray matter
  • MR imaging
  • schizophrenia
  • treatment response

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Szeszko, P. R., Narr, K. L., Phillips, O. R., McCormack, J., Sevy, S., Gunduz-Bruce, H., ... Robinson, D. G. (2012). Magnetic resonance imaging predictors of treatment response in first-episode schizophrenia. Schizophrenia Bulletin, 38(3), 569-578. https://doi.org/10.1093/schbul/sbq126

Magnetic resonance imaging predictors of treatment response in first-episode schizophrenia. / Szeszko, Philip R.; Narr, Katherine L.; Phillips, Owen R.; McCormack, Joanne; Sevy, Serge; Gunduz-Bruce, Handan; Kane, John M.; Bilder, Robert M.; Robinson, Delbert G.

In: Schizophrenia Bulletin, Vol. 38, No. 3, 05.2012, p. 569-578.

Research output: Contribution to journalArticle

Szeszko, PR, Narr, KL, Phillips, OR, McCormack, J, Sevy, S, Gunduz-Bruce, H, Kane, JM, Bilder, RM & Robinson, DG 2012, 'Magnetic resonance imaging predictors of treatment response in first-episode schizophrenia', Schizophrenia Bulletin, vol. 38, no. 3, pp. 569-578. https://doi.org/10.1093/schbul/sbq126
Szeszko PR, Narr KL, Phillips OR, McCormack J, Sevy S, Gunduz-Bruce H et al. Magnetic resonance imaging predictors of treatment response in first-episode schizophrenia. Schizophrenia Bulletin. 2012 May;38(3):569-578. https://doi.org/10.1093/schbul/sbq126
Szeszko, Philip R. ; Narr, Katherine L. ; Phillips, Owen R. ; McCormack, Joanne ; Sevy, Serge ; Gunduz-Bruce, Handan ; Kane, John M. ; Bilder, Robert M. ; Robinson, Delbert G. / Magnetic resonance imaging predictors of treatment response in first-episode schizophrenia. In: Schizophrenia Bulletin. 2012 ; Vol. 38, No. 3. pp. 569-578.
@article{a2ce6d726de145988c00f5fbc326321e,
title = "Magnetic resonance imaging predictors of treatment response in first-episode schizophrenia",
abstract = "Identifying neurobiological predictors of response to antipsychotics in patients with schizophrenia is a critical goal of translational psychiatry. Few studies, however, have investigated the relationship between indices of brain structure and treatment response in the context of a controlled clinical trial. In this study, we sought to identify magnetic resonance (MR) imaging measures of the brain that predict treatment response in patients experiencing a first-episode of schizophrenia. Structural MR imaging scans were acquired in 39 patients experiencing a first-episode of schizophrenia with minimal or no prior exposure to antipsychotics participating in a double-blind 16-week clinical trial comparing the efficacy of risperidone vs olanzapine. Twenty-five patients were classified as responders by meeting operationally defined treatment response criteria on 2 consecutive study visits. Fourteen patients never responded to antipsychotic medication at any point during the clinical trial. MR imaging scans were also acquired in 45 age-and sex-matched healthy volunteers. Cortical pattern matching methods were used to compare cortical thickness and asymmetry measures among groups. Statistical mapping results, confirmed by permutation testing, indicated that responders had greater cortical thickness in occipital regions and greater frontal cortical asymmetry compared with nonresponders. Moreover, among responders, greater thickness in temporal regions was associated with less time to respond. Our findings are consistent with the hypothesis that plasticity and cortical thickness may be more preserved in responders and that MR imaging may assist in the prediction of antipsychotic drug response in patients experiencing a first-episode of schizophrenia.",
keywords = "asymmetry, gray matter, MR imaging, schizophrenia, treatment response",
author = "Szeszko, {Philip R.} and Narr, {Katherine L.} and Phillips, {Owen R.} and Joanne McCormack and Serge Sevy and Handan Gunduz-Bruce and Kane, {John M.} and Bilder, {Robert M.} and Robinson, {Delbert G.}",
year = "2012",
month = "5",
doi = "10.1093/schbul/sbq126",
language = "English",
volume = "38",
pages = "569--578",
journal = "Schizophrenia Bulletin",
issn = "0586-7614",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Magnetic resonance imaging predictors of treatment response in first-episode schizophrenia

AU - Szeszko, Philip R.

AU - Narr, Katherine L.

AU - Phillips, Owen R.

AU - McCormack, Joanne

AU - Sevy, Serge

AU - Gunduz-Bruce, Handan

AU - Kane, John M.

AU - Bilder, Robert M.

AU - Robinson, Delbert G.

PY - 2012/5

Y1 - 2012/5

N2 - Identifying neurobiological predictors of response to antipsychotics in patients with schizophrenia is a critical goal of translational psychiatry. Few studies, however, have investigated the relationship between indices of brain structure and treatment response in the context of a controlled clinical trial. In this study, we sought to identify magnetic resonance (MR) imaging measures of the brain that predict treatment response in patients experiencing a first-episode of schizophrenia. Structural MR imaging scans were acquired in 39 patients experiencing a first-episode of schizophrenia with minimal or no prior exposure to antipsychotics participating in a double-blind 16-week clinical trial comparing the efficacy of risperidone vs olanzapine. Twenty-five patients were classified as responders by meeting operationally defined treatment response criteria on 2 consecutive study visits. Fourteen patients never responded to antipsychotic medication at any point during the clinical trial. MR imaging scans were also acquired in 45 age-and sex-matched healthy volunteers. Cortical pattern matching methods were used to compare cortical thickness and asymmetry measures among groups. Statistical mapping results, confirmed by permutation testing, indicated that responders had greater cortical thickness in occipital regions and greater frontal cortical asymmetry compared with nonresponders. Moreover, among responders, greater thickness in temporal regions was associated with less time to respond. Our findings are consistent with the hypothesis that plasticity and cortical thickness may be more preserved in responders and that MR imaging may assist in the prediction of antipsychotic drug response in patients experiencing a first-episode of schizophrenia.

AB - Identifying neurobiological predictors of response to antipsychotics in patients with schizophrenia is a critical goal of translational psychiatry. Few studies, however, have investigated the relationship between indices of brain structure and treatment response in the context of a controlled clinical trial. In this study, we sought to identify magnetic resonance (MR) imaging measures of the brain that predict treatment response in patients experiencing a first-episode of schizophrenia. Structural MR imaging scans were acquired in 39 patients experiencing a first-episode of schizophrenia with minimal or no prior exposure to antipsychotics participating in a double-blind 16-week clinical trial comparing the efficacy of risperidone vs olanzapine. Twenty-five patients were classified as responders by meeting operationally defined treatment response criteria on 2 consecutive study visits. Fourteen patients never responded to antipsychotic medication at any point during the clinical trial. MR imaging scans were also acquired in 45 age-and sex-matched healthy volunteers. Cortical pattern matching methods were used to compare cortical thickness and asymmetry measures among groups. Statistical mapping results, confirmed by permutation testing, indicated that responders had greater cortical thickness in occipital regions and greater frontal cortical asymmetry compared with nonresponders. Moreover, among responders, greater thickness in temporal regions was associated with less time to respond. Our findings are consistent with the hypothesis that plasticity and cortical thickness may be more preserved in responders and that MR imaging may assist in the prediction of antipsychotic drug response in patients experiencing a first-episode of schizophrenia.

KW - asymmetry

KW - gray matter

KW - MR imaging

KW - schizophrenia

KW - treatment response

UR - http://www.scopus.com/inward/record.url?scp=84860110957&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860110957&partnerID=8YFLogxK

U2 - 10.1093/schbul/sbq126

DO - 10.1093/schbul/sbq126

M3 - Article

C2 - 21084552

AN - SCOPUS:84860110957

VL - 38

SP - 569

EP - 578

JO - Schizophrenia Bulletin

JF - Schizophrenia Bulletin

SN - 0586-7614

IS - 3

ER -